Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer

BACKGROUND: Hormone receptor positive (HR+) breast cancer (BCa) is the most frequently diagnosed subtype. Acquired and intrinsic resistance to conventional endocrine therapy (ET) commonly occurs and prompts incurable metastatic disease. Hence, ET-resistant (ET-R) HR+ BCa presents a therapeutic chall...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cell Commun Signal
Main Authors: Bahnassy, Shaymaa, Thangavel, Hariprasad, Quttina, Maram, Khan, Ashfia Fatima, Dhanyalayam, Dhanya, Ritho, Joan, Karami, Samaneh, Ren, Jing, Bawa-Khalfe, Tasneem
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2020
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7501670/
https://ncbi.nlm.nih.gov/pubmed/32948192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12964-020-00649-z
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki